Table. Prevalence of Positive Screens for MDD, GAD, and PTSD Among US Military Veterans.
Characteristicb | Positive screens, No. (weighted %) | P valuea | ||||
---|---|---|---|---|---|---|
Prepandemic | Peripandemic | 2-y Postonset | Peripandemic vs prepandemic | 2-y postonset vs peripandemic | 2-y postonset vs prepandemic | |
Any positive screen | 174 (8.5) | 249 (12.8) | 144 (7.5) | <.001 | <.001 | .16 |
Sex | ||||||
Female | 33 (15.1) | 52 (24.4) | 31 (15.1) | .007 | <.001 | .79 |
Male | 141 (8.0) | 197 (11.8) | 113 (6.8) | <.001 | <.001 | .09 |
Age | ||||||
18-44 y | 19 (19.0) | 29 (31.2) | 22 (22.1) | <.001 | <.001 | .13 |
45-64 y | 82 (10.5) | 131 (17.5) | 81 (10.1) | <.001 | <.001 | >.99 |
≥65 y | 73 (4.7) | 89 (5.3) | 41 (2.4) | .81 | <.001 | <.001 |
MDD | 102 (5.2) | 138 (7.3) | 85 (4.3) | <.001 | <.001 | .11 |
Sex | ||||||
Female | 15 (5.2) | 20 (8.1) | 15 (5.3) | .55 | .58 | >.99 |
Male | 87 (5.2) | 118 (7.2) | 70 (4.2) | <.001 | <.001 | .08 |
Age | ||||||
18-44 y | 13 (12.2) | 19 (20.5) | 15 (12.6) | <.001 | <.001 | .82 |
45-64 y | 52 (6.8) | 68 (8.6) | 48 (6.0) | .08 | .003 | .36 |
≥65 y | 37 (2.4) | 51 (3.3) | 22 (1.4) | .20 | <.001 | .04 |
GAD | 80 (4.6) | 146 (7.8) | 83 (4.3) | <.001 | <.001 | .92 |
Sex | ||||||
Female | 15 (7.6) | 31 (16.3) | 15 (7.0) | .002 | .001 | >.99 |
Male | 65 (4.4) | 115 (7.1) | 68 (4.2) | <.001 | <.001 | >.99 |
Age | ||||||
18-44 y | 15 (16.0) | 21 (20.2) | 14 (12.5) | .045 | <.001 | .08 |
45-64 y | 36 (4.9) | 82 (11.3) | 53 (7.1) | <.001 | <.001 | .009 |
≥65 y | 29 (1.9) | 43 (2.5) | 16 (0.9) | .74 | <.001 | .003 |
PTSD | 87 (3.8) | 118 (6.2) | 87 (4.7) | <.001 | <.001 | .04 |
Sex | ||||||
Female | 22 (8.1) | 27 (10.5) | 19 (9.9) | .34 | >.99 | .39 |
Male | 65 (3.5) | 91 (5.8) | 68 (4.3) | <.001 | <.001 | .07 |
Age | ||||||
18-44 y | 8 (6.8) | 18 (18.3) | 17 (16.7) | <.001 | .51 | <.001 |
45-64 y | 48 (5.4) | 64 (8.3) | 46 (5.6) | <.001 | <.001 | .77 |
≥65 y | 31 (2.1) | 36 (2.0) | 24 (1.5) | >.99 | .27 | .21 |
Abbreviations: GAD, generalized anxiety disorder; MDD, major depressive disorder; PTSD, posttraumatic stress disorder.
McNemar tests were used to evaluate differences between prevalence estimates at each wave.
Sample sizes for subgroups: female, 232 participants; male 2057 participants; age 18-44 years, 104 participants; age 45-64 years, 676 participants; age ≥65 years, 1509 participants.